ABCC4 (ATP binding cassette subfamily C member 4)

2003-11-01  

Identity

HGNC
LOCATION
13q32.1
LOCUSID
ALIAS
MOAT-B,MOATB,MRP4
FUSION GENES

Other Information

Locus ID:

NCBI: 10257
MIM: 605250
HGNC: 55
Ensembl: ENSG00000125257

Variants:

dbSNP: 10257
ClinVar: 10257
TCGA: ENSG00000125257
COSMIC: ABCC4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000125257ENST00000536256O15439
ENSG00000125257ENST00000629385O15439
ENSG00000125257ENST00000642524A0A2R8YDG7
ENSG00000125257ENST00000643051A0A2R8Y6V8
ENSG00000125257ENST00000643556A0A2R8Y5Z3
ENSG00000125257ENST00000643842Q8IWU1
ENSG00000125257ENST00000645237O15439
ENSG00000125257ENST00000645532A0A2R8YDC1
ENSG00000125257ENST00000646439O15439

Expression (GTEx)

0
5
10
15
20
25

Pathways

PathwaySourceExternal ID
ABC transportersKEGGko02010
ABC transportersKEGGhsa02010
Bile secretionKEGGko04976
Bile secretionKEGGhsa04976
cAMP signaling pathwayKEGGhsa04024
cAMP signaling pathwayKEGGko04024
HemostasisREACTOMER-HSA-109582
Platelet activation, signaling and aggregationREACTOMER-HSA-76002
Response to elevated platelet cytosolic Ca2+REACTOMER-HSA-76005
Platelet degranulationREACTOMER-HSA-114608
Transmembrane transport of small moleculesREACTOMER-HSA-382551
ABC-family proteins mediated transportREACTOMER-HSA-382556
Antifolate resistanceKEGGko01523
Antifolate resistanceKEGGhsa01523

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10005adefovir dipivoxilChemicalPathwayassociated
PA10204tenofovirChemicalClinicalAnnotation, Pathway, VariantAnnotationambiguousPKPD17083032, 17597712, 18398970
PA10227valganciclovirChemicalClinicalAnnotationassociatedPD27402191
PA10804imatinibChemicalClinicalAnnotationassociatedPD23127916
PA128406956fluorouracilChemicalClinicalAnnotationassociatedPKPD19696793
PA151958383Gastrointestinal Stromal TumorsDiseaseClinicalAnnotationassociatedPD23127916
PA164712563BisphosphonatesChemicalClinicalAnnotationassociatedPD
PA164774763latanoprostChemicalClinicalAnnotationassociatedPD25339146
PA165817016Kidney TransplantationDiseaseClinicalAnnotationassociatedPD27402191
PA166163418rucaparibChemicalLabelAnnotationassociated
PA443560Breast NeoplasmsDiseaseClinicalAnnotationassociatedPKPD19696793
PA443842DeathDiseaseVariantAnnotationassociatedPD
PA443937Drug ToxicityDiseaseClinicalAnnotationassociatedPKPD19696793
PA444282Glaucoma, Open-AngleDiseaseClinicalAnnotationassociatedPD25339146
PA444370Heart FailureDiseaseClinicalAnnotationassociatedPD26927285
PA445062NeoplasmsDiseaseClinicalAnnotationassociatedPKPD19696793
PA445187OsteonecrosisDiseaseClinicalAnnotationassociatedPD
PA446116Inflammatory Bowel DiseasesDiseaseClinicalAnnotationassociatedPKPD20393862
PA446155Precursor Cell Lymphoblastic Leukemia-LymphomaDiseaseClinicalAnnotationassociatedPD25348617
PA446157Leukemia, B-Cell, AcuteDiseaseClinicalAnnotationassociatedPKPD23222202
PA446661Carcinoma, Small CellDiseaseClinicalAnnotationassociatedPD23478653
PA447230HIVDiseaseClinicalAnnotation, VariantAnnotationambiguousPKPD16791115, 17083032, 17597712, 18398970
PA448515azathioprineChemicalClinicalAnnotationassociatedPKPD20393862
PA449014cisplatinChemicalClinicalAnnotationassociatedPD23478653
PA449165cyclophosphamideChemicalClinicalAnnotationassociatedPKPD19696793
PA449177cytarabineChemicalMultilinkAnnotationassociated26842729
PA449412doxorubicinChemicalClinicalAnnotationassociatedPKPD19696793
PA449719furosemideChemicalClinicalAnnotationassociatedPD26927285
PA450085irinotecanChemicalClinicalAnnotationassociatedPD23478653
PA450163lamivudineChemicalPathwayassociated
PA450379mercaptopurineChemicalClinicalAnnotation, VariantAnnotationassociatedPKPD20393862
PA450428methotrexateChemicalClinicalAnnotation, PathwayassociatedPKPD23222202, 25348617, 25502615
PA451954zidovudineChemicalClinicalAnnotation, PathwayassociatedPK16791115, 22960662

References

Pubmed IDYearTitleCitations
379889812024ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity.0
379889812024ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity.0
375633612023m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.4
376836412023Structural and mechanistic basis of substrate transport by the multidrug transporter MRP4.4
375633612023m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.4
376836412023Structural and mechanistic basis of substrate transport by the multidrug transporter MRP4.4
346939292022In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4).1
349511412022Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo-optico-neuropathy (SMON).3
352262282022IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.5
352695922022The Daily Expression of ABCC4 at the BCSFB Affects the Transport of Its Substrate Methotrexate.3
352950752022Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets.2
353815632022Drug resistance biomarker ABCC4 of selinexor and immune feature in multiple myeloma.6
346939292022In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4).1
349511412022Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo-optico-neuropathy (SMON).3
352262282022IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.5

Citation

Dessen P

ABCC4 (ATP binding cassette subfamily C member 4)

Atlas Genet Cytogenet Oncol Haematol. 2003-11-01

Online version: http://atlasgeneticsoncology.org/gene/541/abcc4-(atp-binding-cassette-subfamily-c-member-4)